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Leukemoid reaction in a patient with acute lymphoblastic leukemia following the second chemotherapy
Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon 3 ) and bone marrow examination revealed remission. Cytogenetic analysis was normal and this leukocytosis was determined as reactive leukemoid reaction. We aimed to report this case owing to the fact that leukocytosis associated with G-CSF, which is used to increase the leukocyte count during neutropenia, has been reported previously but it occurred after second chemotherapy without G-CSF [4] . We know that this condition is a very rare situation. To the Editor,
The occurrence of persistent neutrophilic leukocytosis above 50,000 cells/µL for reasons other than leukemia is defined as leukemoid reaction. Chronic myelogenous leukemia (CML) and chronic neutrophilic leukemia (CNL) should be excluded, and underlying diseases or causes should be examined, in differential diagnosis. The most commonly observed causes of leukemoid reactions are severe infections, intoxications, malignancies, severe hemorrhage, or acute hemolysis [1] .
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Rarely, leukemoid reaction can be seen in patients with acute leukemia subsequent to chemotherapy, as seen in our patient with acute lymphoblastic leukemia subsequent to pancytopenia due to chemotherapy [2, 3] . A complete blood count of the patient was recovered subsequent to the development of leukemoid reaction. CML and leukemoid pictures tend to be confused. Therefore, these two almost identical conditions must be distinguished through a histological evaluation of bone biopsy and immunochemical staining [5, 6] . It has been reported that in a case with systemic lupus erythrosis, deep myelosuppression occurred due to low dose methotrexate administered for arthritis, and leukemoid reaction developed after the drug was discontinued [7] . The fact that leukemoid reaction may occur due to G-CSFproducing tumors, and the said picture could remit with treatment of the tumor, was demonstrated [8] .
Consequently, the development of leukocytosis due to leukemoid reaction subsequent to chemotherapy without G-CSF in patients with acute leukemia should be kept in mind during the treatment of leukemia. Written, informed consent was obtained from the patient.
